Literature DB >> 6246003

Ischemic cardiovascular complications concurrent with administration of captopril. A clinical note.

K M Baker, D W Johns, C R Ayers, R M Carey.   

Abstract

Administration of potent vasodepressor agents such as the angiotensin converting enzyme inhibitor, captopril, may precipitate myocardial ischemic events in patients with coronary artery disease, particularly if this treatment is preceded by a discontinuation of beta-blocking drugs such as propranolol. In one case studied, a patient experienced three episodes of angina pectoris under these conditions; in another, acute anterior myocardial infarction was suspect.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6246003     DOI: 10.1161/01.hyp.2.1.73

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  6 in total

1.  Chest pain after captopril.

Authors:  J B Davis
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-16

2.  Haemodynamic and myocardial metabolic effects of captopril in chronic heart failure.

Authors:  K Chatterjee; J L Rouleau; W W Parmley
Journal:  Br Heart J       Date:  1982-03

3.  [Results of a 5-year study with captopril in patients with severe therapy-resistant hypertension].

Authors:  J Schrader; G Schoel; F Scheler
Journal:  Klin Wochenschr       Date:  1986-08-01

4.  The variable effects of angiotensin converting enzyme inhibition on myocardial ischaemia in chronic stable angina.

Authors:  J Simon; R Gibbs; P A Crean; L Mockus; C Wright; G C Sutton; K M Fox
Journal:  Br Heart J       Date:  1989-08

Review 5.  Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

6.  Effects of the converting enzyme inhibitor captopril on blood coagulation and fibrinolysis in man.

Authors:  J Schrader; H Köstering; H J Gröne; E J Kirchertz; F Scheler
Journal:  Klin Wochenschr       Date:  1982-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.